Delivery Order SPE2DB24D2018-SPE2DB25FWWS4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rotarix vaccine oral syringes (1.5mL) with a ceiling value of $12,644.74. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with a ceiling value of $6,750.09. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rotarix vaccine oral syringes in 1.5mL units, with a ceiling value of $5,527.46. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $11,462.30. The order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive, non-set-aside delivery of pharmaceutical products to support federal medical supply requirements. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ml with a ceiling value of $39,804.60. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) with a ceiling value of $1,476.68. This non-set-aside, firm fixed price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,214.99 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rotarix vaccine oral syringes (1.5mL). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5ml) under a firm fixed-price contract valued at $8,859.96. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a competitively awarded, non-set-aside delivery order. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWS4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Rotarix vaccine oral syringes (1.5 mL) with a ceiling value of $1,476.68 under a firm fixed price contract type. This non-set-aside award is scheduled for ultimate completion by September 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability across multiple therapeutic domains and competitive performance positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/11/25 |